Research Article
Circulating Exosomal miR-96 as a Novel Biomarker for Radioresistant Non-Small-Cell Lung Cancer
Table 2
Clinical characteristics of patients and healthy individuals of two sets.
| Variable | NSCLC (52) | HV (45) | value | RRP (27) | RSP (25) |
| Age (years) | 53.3 ± 12.1 | 56.8 ± 15.5 | 55.7 ± 13.6 | 0.999 | Sex (male/female) | 18/9 | 15/10 | 26/19 | 0.774 | Smoking | 22 | 19 | 34 | 0.862 | Pathological stage | II | 3 | 2 | — | 0.777 | III | 15 | 13 | IV | 8 | 10 |
| Surgery treatment | 11 | 13 | NA | 0.578 |
| Differentiation status | High | 3 | 2 | NA | 0.923 | Median | 12 | 10 | Low | 12 | 13 |
| Chemotherapy | 25 | 22 | NA | 0.662 | History of COPD | 20 | 21 | NA | 0.503 | Vascular invasion | 9 | 5 | NA | 0.355 |
|
|
RRP: radioresistant patient; RSP: radiosensitive patient; HV: healthy volunteer.
|